Literature DB >> 31206207

Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.

Vincent Puel1, Hélène Théophile2, Isabelle Godard1, Nathalie Raymond1, Ghada Miremont-Salamé2,3, Philippe Gosse4, Jean-Louis Pépin5, Antoine Pariente2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31206207      PMCID: PMC6624382          DOI: 10.1111/bcp.13967

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

Review 1.  Sleep apnea and heart failure: Part II: central sleep apnea.

Authors:  T Douglas Bradley; John S Floras
Journal:  Circulation       Date:  2003-04-08       Impact factor: 29.690

2.  Reversal of Ticagrelor-Induced Arrhythmias and Cheyne-Stokes Respiration With Aminophylline Infusion.

Authors:  Lorenzo Conte; Nicola R Pugliese; Alberto Giannoni
Journal:  J Cardiovasc Pharmacol       Date:  2017-11       Impact factor: 3.105

3.  Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.

Authors:  Vincent Puel; Hélène Théophile; Isabelle Godard; Nathalie Raymond; Ghada Miremont-Salamé; Philippe Gosse; Jean-Louis Pépin; Antoine Pariente
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

4.  Ticagrelor and Central Sleep Apnea.

Authors:  Bruno Revol; Ingrid Jullian-Desayes; Renaud Tamisier; Vincent Puel; Michel Mallaret; Marie Joyeux-Faure; Jean-Louis Pépin
Journal:  J Am Coll Cardiol       Date:  2018-05-22       Impact factor: 24.094

5.  Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.

Authors:  Alberto Giannoni; Michele Emdin; Claudio Passino
Journal:  N Engl J Med       Date:  2016-09-08       Impact factor: 91.245

6.  Dyspnea or Cheyne-Stokes respiration associated with Ticagrelor?

Authors:  V Lamberts; Ph Baele; D Kahn; G Liistro
Journal:  Sleep Med       Date:  2017-10-23       Impact factor: 3.492

7.  Cardiac workload in patients with sleep-disordered breathing early after acute myocardial infarction.

Authors:  Andrea Hetzenecker; Stefan Buchner; Tanja Greimel; Anna Satzl; Andreas Luchner; Kurt Debl; Oliver Husser; Okka W Hamer; Claudia Fellner; Günter A J Riegger; Michael Pfeifer; Michael Arzt
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Central Sleep Apnoea Is Related to the Severity and Short-Term Prognosis of Acute Coronary Syndrome.

Authors:  Marina Florés; Jordi de Batlle; Alicia Sánchez-de-la-Torre; Manuel Sánchez-de-la-Torre; Albina Aldomá; Fernando Worner; Estefanía Galera; Asunción Seminario; Gerard Torres; Mireia Dalmases; Josep M Montserrat; Onintza Garmendia; Ferran Barbé
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

  10 in total
  1 in total

1.  Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.

Authors:  Vincent Puel; Hélène Théophile; Isabelle Godard; Nathalie Raymond; Ghada Miremont-Salamé; Philippe Gosse; Jean-Louis Pépin; Antoine Pariente
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.